Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (4 quarters reported)
$95.7M in Q4 2024 → — now. Hover for any quarter.
As reported for the quarter ended September 30, 2025. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| 0 0 | NaN% | New | 0 | — |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 3 quarters.
quarter ended September 30, 2025 · filed November 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Abivax Sa | Exited | −167,350 | −$1.28M | — |
| Akero Therapeutics Inc | Exited | −22,500 | −$1.2M | — |
| Amylyx Pharmaceuticals Inc | Exited | −120,119 | −$770K | — |
| Centessa Pharmaceuticals PLC | Exited | −52,500 | −$690K | — |
| Evolus Inc | Exited | −60,000 | −$553K | — |
| Rezolute Inc | Exited | −119,294 | −$532K | — |
| Merus N V | Exited | −9,000 | −$473K | — |
| Kalvista Pharmaceuticals Inc | Exited | −40,000 | −$452K | — |
| Fulcrum Therapeutics Inc | Exited | −40,353 | −$278K | — |
| Apogee Therapeutics Inc | Exited | −6,000 | −$261K | — |
Showing the 10 largest of 21 changes.
quarter ended June 30, 2025 · filed August 14, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Abivax Sa | Trimmed | −932,304 | −$7.13M | 16.3% |
| Merus N V | Trimmed | −115,657 | −$6.08M | 6.0% |
| Kalvista Pharmaceuticals Inc | Trimmed | −418,302 | −$4.73M | 5.8% |
| Apogee Therapeutics Inc | Trimmed | −104,000 | −$4.52M | 3.3% |
| Centessa Pharmaceuticals PLC | Trimmed | −330,024 | −$4.34M | 8.8% |
| Alkermes PLC | Exited | −115,000 | −$3.8M | — |
| AT Aerovate Therapeutics Inc | Exited | −1,421,568 | −$3.57M | — |
| Bridgebio Pharma Inc | Trimmed | −76,000 | −$3.28M | 2.2% |
| Evolus Inc | Trimmed | −352,754 | −$3.25M | 7.0% |
| Zura Bio Ltd | Exited | −2,329,384 | −$3M | — |
Showing the 10 largest of 46 changes.
quarter ended March 31, 2025 · filed May 15, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| SS SPDR Ser Tr | Exited | −175,000 | −$15.8M | — |
| IQ Invesco Qqq Tr | Exited | −25,000 | −$12.8M | — |
| IT Ishares Tr | Exited | −100,000 | −$8.73M | — |
| Merus N V | Added | +102,922 | +$4.33M | 7.6% |
| Abivax Sa | Added | +508,401 | +$3.18M | 9.9% |
| Bridgebio Pharma Inc | New | +80,000 | +$2.77M | 4.0% |
| Apellis Pharmaceuticals Inc | Exited | −80,000 | −$2.55M | — |
| Springworks Therapeutics Inc | New | +52,500 | +$2.32M | 3.3% |
| Tg Therapeutics Inc | Exited | −75,000 | −$2.26M | — |
| Beam Therapeutics Inc | New | +92,754 | +$1.81M | 2.6% |
Showing the 10 largest of 47 changes.
Loading...
